{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:11:52Z","timestamp":1793293912815,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA214588 (ARG)"],"award-info":[{"award-number":["R01CA214588 (ARG)"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-024-01824-5","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T10:02:48Z","timestamp":1729245768000},"page":"2836-2846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Multinational epidemiological analysis of oral human papillomavirus incidence in 3,137 men"],"prefix":"10.1038","volume":"9","author":[{"given":"Racheal S.","family":"Dube Mandishora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittney L.","family":"Dickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Sirak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Isaacs-Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Rathwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Abrahamsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4594-6601","authenticated-orcid":false,"given":"Michael J.","family":"Schell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Lazcano-Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa L.","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5440-8859","authenticated-orcid":false,"given":"Anna R.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"key":"1824_CR1","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","volume":"8","author":"C de Martel","year":"2020","unstructured":"de Martel, C., Georges, D., Bray, F., Ferlay, J. & Clifford, G. M. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob. Health 8, e180\u2013e190 (2020).","journal-title":"Lancet Glob. Health"},{"key":"1824_CR2","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1200\/JCO.2013.50.3870","volume":"31","author":"AK Chaturvedi","year":"2013","unstructured":"Chaturvedi, A. K. et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J. Clin. Oncol. 31, 4550\u20134559 (2013).","journal-title":"J. Clin. Oncol."},{"key":"1824_CR3","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1158\/1055-9965.EPI-22-0642","volume":"31","author":"V Lorenzoni","year":"2022","unstructured":"Lorenzoni, V. et al. The current burden of oropharyngeal cancer: a global assessment based on GLOBOCAN 2020. Cancer Epidemiol. Biomarkers Prev. 31, 2054\u20132062 (2022).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1824_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1824_CR5","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1200\/JCO.19.00370","volume":"37","author":"JE Tota","year":"2019","unstructured":"Tota, J. E. et al. Evolution of the oropharynx cancer epidemic in the United States: moderation of increasing incidence in younger individuals and shift in the burden to older individuals. J. Clin. Oncol. 37, 1538\u20131546 (2019).","journal-title":"J. Clin. Oncol."},{"key":"1824_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.926555","volume":"12","author":"F Guo","year":"2022","unstructured":"Guo, F., Chang, M., Scholl, M., McKinnon, B. & Berenson, A. B. Trends in oropharyngeal cancer incidence among adult men and women in the United States From 2001 to 2018. Front. Oncol. 12, 926555 (2022).","journal-title":"Front. Oncol."},{"key":"1824_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83197-x","volume":"11","author":"I Ganly","year":"2021","unstructured":"Ganly, I. et al. Case control study comparing the HPV genome in patients with oral cavity squamous cell carcinoma to normal patients using metagenomic shotgun sequencing. Sci. Rep. 11, 3867 (2021).","journal-title":"Sci. Rep."},{"key":"1824_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkaa047","volume":"4","author":"G D\u2019Souza","year":"2020","unstructured":"D\u2019Souza, G. et al. Long-term persistence of oral HPV over 7 years of follow-up. JNCI Cancer Spectr. 4, pkaa047 (2020).","journal-title":"JNCI Cancer Spectr."},{"key":"1824_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-014-0668-z","volume":"14","author":"F van Aar","year":"2014","unstructured":"van Aar, F. et al. Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study. BMC Infect. Dis. 14, 668 (2014).","journal-title":"BMC Infect. Dis."},{"key":"1824_CR10","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1002\/ijc.33442","volume":"148","author":"A Antonsson","year":"2021","unstructured":"Antonsson, A. et al. Natural history of oral HPV infection: longitudinal analyses in prospective cohorts from Australia. Int. J. Cancer 148, 1964\u20131972 (2021).","journal-title":"Int. J. Cancer"},{"key":"1824_CR11","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1097\/QAD.0b013e328362395c","volume":"27","author":"SH Mooij","year":"2013","unstructured":"Mooij, S. H. et al. Oral human papillomavirus infection in HIV-negative and HIV-infected MSM. AIDS 27, 2117\u20132128 (2013).","journal-title":"AIDS"},{"key":"1824_CR12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/sextrans-2019-054301","volume":"96","author":"M Giuliani","year":"2020","unstructured":"Giuliani, M. et al. Oral human papillomavirus infection in HIV-infected and HIV-uninfected MSM: the OHMAR prospective cohort study. Sex. Transm. Infect. 96, 528\u2013536 (2020).","journal-title":"Sex. Transm. Infect."},{"key":"1824_CR13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0140-6736(13)60809-0","volume":"382","author":"AR Kreimer","year":"2013","unstructured":"Kreimer, A. R. et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet 382, 877\u2013887 (2013).","journal-title":"Lancet"},{"key":"1824_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/aje\/kwu247","volume":"181","author":"DC Beachler","year":"2015","unstructured":"Beachler, D. C. et al. Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. Am. J. Epidemiol. 181, 40\u201353 (2015).","journal-title":"Am. J. Epidemiol."},{"key":"1824_CR15","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/S0140-6736(10)62342-2","volume":"377","author":"AR Giuliano","year":"2011","unstructured":"Giuliano, A. R. et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 377, 932\u2013940 (2011).","journal-title":"Lancet"},{"key":"1824_CR16","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciw140","volume":"62","author":"AG Nyitray","year":"2016","unstructured":"Nyitray, A. G. et al. Incidence, duration, persistence, and factors associated with high-risk anal human papillomavirus persistence among HIV-negative men who have sex with men: a multinational study. Clin. Infect. Dis. 62, 1367\u20131374 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"1824_CR17","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1158\/1055-9965.EPI-10-1160","volume":"20","author":"B Lu","year":"2011","unstructured":"Lu, B. et al. Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study). Cancer Epidemiol. Biomarkers Prev. 20, 990\u20131002 (2011).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1824_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pvr.2015.06.007","volume":"1","author":"AR Giuliano","year":"2015","unstructured":"Giuliano, A. R. et al. Seroconversion following anal and genital HPV infection in men: the HIM study. Papillomavirus Res. 1, 109\u2013115 (2015).","journal-title":"Papillomavirus Res."},{"key":"1824_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvr.2022.200236","volume":"13","author":"DR Brown","year":"2022","unstructured":"Brown, D. R. et al. Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women. Tumour Virus Res. 13, 200236 (2022).","journal-title":"Tumour Virus Res."},{"key":"1824_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1314-0","volume":"15","author":"AF Brouwer","year":"2015","unstructured":"Brouwer, A. F., Eisenberg, M. C., Carey, T. E. & Meza, R. Trends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003\u20132012. BMC Infect. Dis. 15, 575 (2015).","journal-title":"BMC Infect. Dis."},{"key":"1824_CR21","doi-asserted-by":"publisher","first-page":"6066","DOI":"10.1158\/0008-5472.CAN-16-0224","volume":"76","author":"SJ Pamnani","year":"2016","unstructured":"Pamnani, S. J. et al. Impact of serum antibodies to HPV serotypes 6, 11, 16, and 18 to risks of subsequent genital HPV infections in men: the HIM study. Cancer Res. 76, 6066\u20136075 (2016).","journal-title":"Cancer Res."},{"key":"1824_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/infdis\/jiw083","volume":"214","author":"CM Pierce Campbell","year":"2016","unstructured":"Pierce Campbell, C. M. et al. Human Papillomavirus (HPV) L1 serum antibodies and the risk of subsequent oral HPV acquisition in men: the HIM study. J. Infect. Dis. 214, 45\u201348 (2016).","journal-title":"J. Infect. Dis."},{"key":"1824_CR23","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/infdis\/jiy300","volume":"218","author":"SJ Pamnani","year":"2018","unstructured":"Pamnani, S. J. et al. Recurrence of genital infections with 9 human papillomavirus (HPV) vaccine types (6, 11, 16, 18, 31, 33, 45, 52, and 58) among men in the HPV Infection in Men (HIM) study. J. Infect. Dis. 218, 1219\u20131227 (2018).","journal-title":"J. Infect. Dis."},{"key":"1824_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1056\/NEJMoa0909537","volume":"364","author":"AR Giuliano","year":"2011","unstructured":"Giuliano, A. R. et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N. Engl. J. Med. 364, 401\u2013411 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1824_CR25","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/cid\/ciy1081","volume":"69","author":"H Mehanna","year":"2019","unstructured":"Mehanna, H. et al. Human papillomavirus (HPV) vaccine effectiveness and potential herd immunity for reducing oncogenic oropharyngeal HPV-16 prevalence in the United Kingdom: a cross-sectional study. Clin. Infect. Dis. 69, 1296\u20131302 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"1824_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1200\/JCO.2017.75.0141","volume":"36","author":"AK Chaturvedi","year":"2018","unstructured":"Chaturvedi, A. K. et al. Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States. J. Clin. Oncol. 36, 262\u2013267 (2018).","journal-title":"J. Clin. Oncol."},{"key":"1824_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamaoto.2021.3567","volume":"148","author":"H Damgacioglu","year":"2022","unstructured":"Damgacioglu, H. et al. Oropharyngeal cancer incidence and mortality trends in all 50 States in the US, 2001\u20132017. JAMA Otolaryngol. Head Neck Surg. 148, 155\u2013165 (2022).","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"1824_CR28","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1002\/cncr.31385","volume":"124","author":"MJ Windon","year":"2018","unstructured":"Windon, M. J. et al. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults. Cancer. 124, 2993\u20132999 (2018).","journal-title":"Cancer."},{"key":"1824_CR29","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/jnci\/djz227","volume":"112","author":"EA Burger","year":"2020","unstructured":"Burger, E. A. et al. Estimating the natural history of cervical carcinogenesis using simulation models: a CISNET comparative analysis. J. Natl Cancer Inst. 112, 955\u2013963 (2020).","journal-title":"J. Natl Cancer Inst."},{"key":"1824_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","volume":"47","author":"S de Sanjos\u00e9","year":"2018","unstructured":"de Sanjos\u00e9, S., Brotons, M. & Pav\u00f3n, M. A. The natural history of human papillomavirus infection. Best Pract. Res. Clin. Obstet. Gynaecol. 47, 2\u201313 (2018).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"1824_CR31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1158\/1940-6207.CAPR-14-0296","volume":"8","author":"CM Pierce Campbell","year":"2015","unstructured":"Pierce Campbell, C. M. et al. Long-term persistence of oral human papillomavirus type 16: the HPV Infection In Men (HIM) study. Cancer Prev. Res. 8, 190\u2013196 (2015).","journal-title":"Cancer Prev. Res."},{"key":"1824_CR32","doi-asserted-by":"publisher","first-page":"e3227","DOI":"10.1093\/cid\/ciaa1701","volume":"73","author":"D Bettampadi","year":"2021","unstructured":"Bettampadi, D. et al. Factors associated with persistence and clearance of high-risk oral human papillomavirus (HPV) among participants in the HPV Infection in Men (HIM) Study. Clin. Infect. Dis. 73, e3227\u2013e3234 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"1824_CR33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/jnci\/djad009","volume":"115","author":"R Landy","year":"2023","unstructured":"Landy, R. et al. Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling study. J. Natl Cancer. Inst. 115, 429\u2013436 (2023).","journal-title":"J. Natl Cancer. Inst."},{"key":"1824_CR34","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/cid\/cix475","volume":"65","author":"EA Burger","year":"2017","unstructured":"Burger, E. A., Kim, J. J., Sy, S. & Castle, P. E. Age of acquiring causal human papillomavirus (hpv) infections: leveraging simulation models to explore the natural history of HPV-induced cervical cancer. Clin. Infect. Dis. 65, 893\u2013899 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"1824_CR35","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1158\/0008-5472.CAN-14-2843","volume":"75","author":"AK Chaturvedi","year":"2015","unstructured":"Chaturvedi, A. K. et al. NHANES 2009\u20132012 findings: association of sexual behaviors with higher prevalence of oral oncogenic human papillomavirus infections in U.S. men. Cancer Res. 75, 2468\u20132477 (2015).","journal-title":"Cancer Res."},{"key":"1824_CR36","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/OLQ.0000000000000845","volume":"45","author":"SE Oliver","year":"2018","unstructured":"Oliver, S. E. et al. Risk factors for oral human papillomavirus infection among young men who have sex with men\u20142 Cities, United States, 2012\u20132014. Sex. Transm. Dis. 45, 660\u2013665 (2018).","journal-title":"Sex. Transm. Dis."},{"key":"1824_CR37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/OLQ.0b013e31824f1c65","volume":"39","author":"RKL Pickard","year":"2012","unstructured":"Pickard, R. K. L., Xiao, W., Broutian, T. R., He, X. & Gillison, M. L. The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18\u201330 years. Sex. Transm. Dis. 39, 559\u2013566 (2012).","journal-title":"Sex. Transm. Dis."},{"key":"1824_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/alcalc\/ags100","volume":"48","author":"F Turati","year":"2012","unstructured":"Turati, F. et al. A meta-analysis of alcohol drinking and oral and pharyngeal cancers: results from subgroup analyses. Alcohol Alcohol. 48, 107\u2013118 (2012).","journal-title":"Alcohol Alcohol."},{"key":"1824_CR39","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2077065","volume":"18","author":"MA Casta\u00f1eda-Avila","year":"2022","unstructured":"Casta\u00f1eda-Avila, M. A. et al. Sex and educational attainment differences in HPV knowledge and vaccination awareness among unvaccinated-sexually active adults in Puerto Rico. Hum. Vaccin. Immunother. 18, 2077065 (2022).","journal-title":"Hum. Vaccin. Immunother."},{"key":"1824_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-7923-6","volume":"19","author":"MA Brondani","year":"2019","unstructured":"Brondani, M. A., Siqueira, A. B. & Alves, C. M. C. Exploring lay public and dental professional knowledge around HPV transmission via oral sex and oral cancer development. BMC Public Health 19, 1529 (2019).","journal-title":"BMC Public Health"},{"key":"1824_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1370\/afm.2761","volume":"20","author":"A Strome","year":"2022","unstructured":"Strome, A., Moore-Petinak, N., Waselewski, M. & Chang, T. Youths\u2019 knowledge and perceptions of health risks associated with unprotected oral sex. Ann. Fam. Med. 20, 72\u201376 (2022).","journal-title":"Ann. Fam. Med."},{"key":"1824_CR42","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/OLQ.0000000000001237","volume":"47","author":"D Gesink","year":"2020","unstructured":"Gesink, D., Salway, T., Kimura, L. & Connell, J. sexual health knowledge, attitudes, and perceptions among men who have sex with men during co-occurring sexually transmitted infection epidemics in Toronto, Canada: a qualitative study. Sex. Transm. Dis. 47, 658\u2013662 (2020).","journal-title":"Sex. Transm. Dis."},{"key":"1824_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-015-0111-x","volume":"15","author":"J Dang","year":"2015","unstructured":"Dang, J., Feng, Q., Eaton, K. D., Jang, H. & Kiviat, N. B. Detection of HPV in oral rinse samples from OPSCC and non-OPSCC patients. BMC Oral Health 15, 126 (2015).","journal-title":"BMC Oral Health"},{"key":"1824_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2020.100199","volume":"9","author":"D Bettampadi","year":"2020","unstructured":"Bettampadi, D. et al. Oral HPV prevalence assessment by linear array vs. SPF10 PCR-DEIA-LiPA25 system in the HPV Infection in Men (HIM) study. Papillomavirus Res. 9, 100199 (2020).","journal-title":"Papillomavirus Res."},{"key":"1824_CR45","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1158\/1055-9965.EPI-08-0151","volume":"17","author":"AR Giuliano","year":"2008","unstructured":"Giuliano, A. R. et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol. Biomarkers Prev. 17, 2036\u20132043 (2008).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1824_CR46","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/ijc.33732","volume":"149","author":"BL Dickey","year":"2021","unstructured":"Dickey, B. L. et al. Sequential acquisition of human papillomavirus infection between genital and oral anatomic sites in males. Int. J. Cancer 149, 1483\u20131494 (2021).","journal-title":"Int. J. Cancer"},{"key":"1824_CR47","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1158\/1055-9965.EPI-10-0682","volume":"20","author":"AR Kreimer","year":"2011","unstructured":"Kreimer, A. R. et al. The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol. Biomarkers Prev. 20, 172\u2013182 (2011).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1824_CR48","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1128\/JCM.37.8.2508-2517.1999","volume":"37","author":"B Kleter","year":"1999","unstructured":"Kleter, B. et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37, 2508\u20132517 (1999).","journal-title":"J. Clin. Microbiol."},{"key":"1824_CR49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jviromet.2015.01.001","volume":"215\u2013216","author":"DT Geraets","year":"2015","unstructured":"Geraets, D. T. et al. The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra. J. Virol. Methods 215\u2013216, 22\u201329 (2015).","journal-title":"J. Virol. Methods"}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-024-01824-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-024-01824-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-024-01824-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T01:06:22Z","timestamp":1730855182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-024-01824-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["1824"],"URL":"https:\/\/doi.org\/10.1038\/s41564-024-01824-5","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"assertion":[{"value":"25 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.R.G. reports grants and personal fees from Merck & Co. outside of the submitted work. L.L.V. is an occasional speaker for HPV prophylactic vaccines of Merck, Sharp & Dohme. All other authors report no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}